Abstract
AIM: Repeated applications of High Concentration Capsaicin 8% Topical System (HCCTS) for 52 weeks was investigated in patients with PDPN (PACE, Vinik et al 2016 and 2019) and patients with non-diabetic PNP (STRIDE, Gálvez et al, 2017). In PACE, HCCTS demonstrated greater efficacy than SOC and that differential treatment effect increased over time whereas in STRIDE, a subset of patients who received 4 consecutive HCCTS treatments displayed reduction in average daily pain scores. We conducted an analysis of those 2 studies considering a subset of subjects defined as initial non-responders to provide responder rates insights beyond the first HCCTS application.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
